Acquisition of rights to an anti-coagulant product from Novartis

Aspen is pleased to announce that Aspen Global Incorpor… 继续阅读Acquisition of rights to an anti-coagulant product from Novartis

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.